Additionally, in advanced liver fibrosis, activated HSCs produce TGF-β, which can suppress NK cell antifibrotic functions, such as degranulation and interferon-gamma (IFN-γ) production, thereby promoting the progression of liver fibrosis (149). This evidence concerns the gene TGFB1 and Hepatic fibrosis.